中文
Company News
- Illumina Introduces the MiSeq i100 Series: its Simplest, Fastest Benchtop Sequencers 10/15/2024
- Illumina Launches New Oncology Menu for NovaSeq X Series Customers 8/6/2024
- Illumina Acquires Fluent BioSciences to Accelerate Single-cell Analysis and Discovery to a... 7/10/2024
- Illumina Inc: Giving Students a New Window on Genomic Technologies 4/2/2024
- Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer 9/12/2023
- Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detec... 5/25/2022
- Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines 4/28/2022
- Illumina Adds Seven Genomics Startups to Accelerator Program 9/17/2021
- Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan 1/12/2021
- Illumina to Acquire Grail for $8B in Cash and Stock 9/22/2020
- Illumina Acquires French Genomic Data-Compression Startup Enancio 7/16/2020
- Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generatio... 6/19/2020
- Illumina Snares First FDA Emergency Use Authorization for NGS-Based SARS-CoV-2 Test 6/11/2020
- Illumina Sues BGI Again, Alleging New CoolMPS Chemistry Infringes SBS Patents 3/2/2020
- Illumina Foundation and Discovery Education Launch New DNA Decoded Resources 10/12/2019
- Illumina Announces a New Genotyping Array and Scientific Contribution to Three Genome Cent... 12/28/2018
- Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Ge... 1/11/2017
- Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust S... 1/11/2017
- Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief... 12/8/2016
- Illumina Launches iHope Program to Identify Causes of Undiagnosed Genetic Diseases in Chil... 12/2/2016